DK2996710T3 - Aktivt stof til behandling af sarkopeni - Google Patents
Aktivt stof til behandling af sarkopeni Download PDFInfo
- Publication number
- DK2996710T3 DK2996710T3 DK14719793.3T DK14719793T DK2996710T3 DK 2996710 T3 DK2996710 T3 DK 2996710T3 DK 14719793 T DK14719793 T DK 14719793T DK 2996710 T3 DK2996710 T3 DK 2996710T3
- Authority
- DK
- Denmark
- Prior art keywords
- sarcopenia
- treatment
- active substance
- substance
- active
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title 1
- 208000001076 sarcopenia Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102013104897.8A DE102013104897A1 (de) | 2013-05-13 | 2013-05-13 | Wirkstoff zur Behandlung von Sarkopenie |
| PCT/EP2014/058673 WO2014183989A1 (de) | 2013-05-13 | 2014-04-29 | Wirkstoff zur behandlung von sarkopenie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2996710T3 true DK2996710T3 (da) | 2021-03-29 |
Family
ID=50588721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14719793.3T DK2996710T3 (da) | 2013-05-13 | 2014-04-29 | Aktivt stof til behandling af sarkopeni |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20160051618A1 (da) |
| EP (1) | EP2996710B1 (da) |
| CN (1) | CN105209059B (da) |
| AU (1) | AU2014267613B2 (da) |
| BR (1) | BR112015028249A2 (da) |
| CA (1) | CA2928222C (da) |
| CL (2) | CL2015003326A1 (da) |
| DE (1) | DE102013104897A1 (da) |
| DK (1) | DK2996710T3 (da) |
| ES (1) | ES2857652T3 (da) |
| MX (1) | MX369238B (da) |
| PL (1) | PL2996710T3 (da) |
| PT (1) | PT2996710T (da) |
| RU (1) | RU2679802C2 (da) |
| WO (1) | WO2014183989A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102013104897A1 (de) | 2013-05-13 | 2014-11-13 | Gelita Ag | Wirkstoff zur Behandlung von Sarkopenie |
| DE102018104590A1 (de) * | 2018-02-28 | 2019-08-29 | Gelita Ag | Nutrazeutische oder pharmazeutische Zusammensetzung |
| US11998654B2 (en) | 2018-07-12 | 2024-06-04 | Bard Shannon Limited | Securing implants and medical devices |
| MX2021014268A (es) * | 2021-11-19 | 2022-02-16 | Univ Mexico Nac Autonoma | Proteina optimizada que comprende los aminoacidos esenciales para la nutricion humana. |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU648140B2 (en) * | 1991-02-01 | 1994-04-14 | Virtual Drug Development, Inc. | Reverse antimicrobial peptides and antimicrobial compositions |
| US6476005B1 (en) * | 1998-03-24 | 2002-11-05 | George D. Petito | Oral and injectable nutritional composition |
| US6107460A (en) * | 1999-03-01 | 2000-08-22 | The Board Of Regents Of The University Of Oklahoma | Antimicrobial peptides and methods of use thereof |
| US8211477B2 (en) * | 2007-10-17 | 2012-07-03 | Biova, L.L.C. | Solubilized protein composition obtained from eggshell membrane |
| DE102009030351A1 (de) * | 2009-06-22 | 2010-12-23 | Gelita Ag | Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen |
| TWI526161B (zh) * | 2010-06-10 | 2016-03-21 | 亞培公司 | 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液 |
| DE102010060564A1 (de) * | 2010-11-15 | 2012-05-16 | Gelita Ag | Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel |
| US10869843B2 (en) * | 2010-11-23 | 2020-12-22 | Chemi Nutra | Method for increasing muscle mass and strength |
| DE102011000997A1 (de) * | 2011-03-01 | 2012-09-06 | Gelita Ag | Zusammensetzung für Ernährungszwecke |
| WO2012143324A1 (en) * | 2011-04-19 | 2012-10-26 | Bioiberica, S.A. | Cartilage product |
| US20130065823A1 (en) * | 2011-09-14 | 2013-03-14 | Sergio Ammirata | Supplement for Strengthening the Muscles of a Human |
| JP6222663B2 (ja) | 2012-08-24 | 2017-11-01 | 国立大学法人徳島大学 | 筋委縮抑制剤 |
| DE102012110612A1 (de) | 2012-11-06 | 2014-05-08 | Gelita Ag | Kollagenhydrolysat und dessen Verwendung |
| US20140296137A1 (en) * | 2013-04-01 | 2014-10-02 | Los Alamos National Security, Llc | Methods and compositions for controlling rotifers |
| DE102013104897A1 (de) | 2013-05-13 | 2014-11-13 | Gelita Ag | Wirkstoff zur Behandlung von Sarkopenie |
-
2013
- 2013-05-13 DE DE102013104897.8A patent/DE102013104897A1/de not_active Withdrawn
-
2014
- 2014-04-29 ES ES14719793T patent/ES2857652T3/es active Active
- 2014-04-29 DK DK14719793.3T patent/DK2996710T3/da active
- 2014-04-29 BR BR112015028249A patent/BR112015028249A2/pt active Search and Examination
- 2014-04-29 PT PT147197933T patent/PT2996710T/pt unknown
- 2014-04-29 CA CA2928222A patent/CA2928222C/en active Active
- 2014-04-29 EP EP14719793.3A patent/EP2996710B1/de active Active
- 2014-04-29 PL PL14719793T patent/PL2996710T3/pl unknown
- 2014-04-29 MX MX2015015680A patent/MX369238B/es active IP Right Grant
- 2014-04-29 AU AU2014267613A patent/AU2014267613B2/en active Active
- 2014-04-29 RU RU2015153242A patent/RU2679802C2/ru active
- 2014-04-29 WO PCT/EP2014/058673 patent/WO2014183989A1/de active Application Filing
- 2014-04-29 CN CN201480027100.1A patent/CN105209059B/zh active Active
-
2015
- 2015-11-04 US US14/931,989 patent/US20160051618A1/en not_active Abandoned
- 2015-11-12 CL CL2015003326A patent/CL2015003326A1/es unknown
-
2018
- 2018-11-23 CL CL2018003346A patent/CL2018003346A1/es unknown
-
2019
- 2019-01-25 US US16/257,527 patent/US20190151399A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN105209059B (zh) | 2021-11-02 |
| DE102013104897A1 (de) | 2014-11-13 |
| MX369238B (es) | 2019-11-01 |
| RU2015153242A (ru) | 2017-06-19 |
| CN105209059A (zh) | 2015-12-30 |
| CA2928222C (en) | 2021-02-16 |
| AU2014267613A1 (en) | 2015-11-26 |
| CL2018003346A1 (es) | 2019-02-01 |
| ES2857652T3 (es) | 2021-09-29 |
| EP2996710B1 (de) | 2021-03-03 |
| US20160051618A1 (en) | 2016-02-25 |
| PT2996710T (pt) | 2021-03-26 |
| RU2015153242A3 (da) | 2018-03-01 |
| WO2014183989A1 (de) | 2014-11-20 |
| AU2014267613B2 (en) | 2017-06-15 |
| CA2928222A1 (en) | 2014-11-20 |
| PL2996710T3 (pl) | 2021-06-28 |
| MX2015015680A (es) | 2016-03-15 |
| RU2679802C2 (ru) | 2019-02-13 |
| CL2015003326A1 (es) | 2016-07-15 |
| BR112015028249A2 (pt) | 2017-07-25 |
| US20190151399A1 (en) | 2019-05-23 |
| EP2996710A1 (de) | 2016-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3125875T3 (da) | Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande | |
| DK3076967T3 (da) | Fremgangsmåder til behandling af residuelle symptomer på skizofreni | |
| DK3329884T3 (da) | Implanterbar indretning til behandling af glaukom | |
| DK3035926T3 (da) | Forbindelser og fremgangsmåder til behandling af en epilepsilidelse | |
| DK3492632T3 (da) | Metoder til behandling af lithiumholdige materialer | |
| DK2983787T3 (da) | Fremgangsmåde til behandling af posttraumatisk stresssygdom | |
| DK2958900T3 (da) | 2-aminopyrimidinderivater til behandling af virusinfektioner | |
| DK3043816T3 (da) | Anti-b7-h1-antistoffer til behandling af tumorer | |
| DK2964315T3 (da) | System til behandling af neuromotorisk dysfunktion | |
| DK2968208T3 (da) | Behandling af kataplexi | |
| DK3033086T3 (da) | Kombinationsterapi til behandling af cancer | |
| DK2981255T3 (da) | Terapeutiske anvendelser af empagliflozin | |
| DK3010895T3 (da) | Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner | |
| DK3049059T3 (da) | Intranasal dhe formulering til behandlingen af hovedpine | |
| DK3007726T3 (da) | Fremgangsmåder til behandling af en tauopati | |
| DK2976359T4 (da) | Fremgangsmåder til behandling af osteogenesis imperfecta | |
| DK3524255T3 (da) | Sammensætning til behandling af acne | |
| DK3157534T3 (da) | Acetylcholinesterasehæmmere til behandling af dermatologiske tilstande | |
| DK3016493T3 (da) | Behandling til desinficering af frø | |
| DK3019166T3 (da) | A Pharmaceutical Combination for the Treatment of Melanoma | |
| DK2992104T3 (da) | Fremgangsmåde til ekspression | |
| DK2994157T3 (da) | Tafa4-forbindelser og anvendelser deraf til behandling af smerte | |
| DK3569166T3 (da) | Indretning til akut behandling af hjertestop | |
| BR112016026046A2 (pt) | Uso de compostos de tienotriazolodiazepina | |
| DK2961378T3 (da) | Fremgangsmåder til behandlingen af mitochondrisk sygdom |